RKIP has been further reported to suppress the expression of pro-inflammatory cytokines and chemokines by inhibiting NF-κB signaling, thereby limiting chronic inflammation, tumor invasion, and metastatic dissemination [27,78,81]. This evidence concerns the gene PEBP1 and neoplasm.